RISKS AND UNCERTAINTIES (Details Narrative) - USD ($) |
3 Months Ended | 6 Months Ended | 12 Months Ended | ||
|---|---|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
Dec. 31, 2025 |
|
| Accumulated deficit | $ (34,444,821) | $ (34,444,821) | $ (28,839,889) | ||
| Ownership interests | 4.99% | 4.99% | |||
| Recognized goodwill | $ 800,027 | $ 800,027 | |||
| Inventory reserve | 6,596,096 | 6,596,096 | 0 | ||
| Inventory reserve expense (allowance) | 5,007,427 | ||||
| Impairment of hemp-specific fixed assets | 64,628 | 208,049 | |||
| Operating expenses | 2,178,388 | $ 3,356,034 | 5,037,569 | $ 5,901,813 | |
| Ablis [Member] | |||||
| Total investment | 399,200 | 399,200 | |||
| Goodwill carrying value | 0 | ||||
| Goodwill impairment charges | 0 | ||||
| Oculus Goodwill [Member] | |||||
| Total investment | 399,200 | ||||
| Goodwill carrying value | 0 | ||||
| Goodwill impairment charges | 800,027 | ||||
| Lifted Goodwill [Member] | |||||
| Goodwill impairment charges | $ 22,292,767 | ||||
| Hemp-Derived [Member] | |||||
| Inventory reserve | 5,007,427 | 5,007,427 | |||
| Operating expenses | 736,000 | ||||
| kratom Derived Inventory [Member] | |||||
| Inventory reserve | $ 1,434,458 | $ 1,434,458 | |||
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of impairment loss from asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of valuation reserve for inventory. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Sum of the carrying amounts as of the balance sheet date of all investments. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of accumulated undistributed earnings (deficit). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|